DRI Healthcare Trust – TSX:DHT-U.TO

DRI Healthcare Trust stock price today

$5.65
-2.60
-31.6%
Financial Health
0
1
2
3
4
5
6
7
8
9

DRI Healthcare Trust stock price monthly change

-5.38%
month

DRI Healthcare Trust stock price quarterly change

-5.38%
quarter

DRI Healthcare Trust stock price yearly change

-13.05%
year

DRI Healthcare Trust key metrics

Market Cap
461.45M
Enterprise value
375.42M
P/E
38.26
EV/Sales
2.62
EV/EBITDA
3.95
Price/Sales
3.25
Price/Book
0.88
PEG ratio
-2.29
EPS
2.19
Revenue
222.64M
EBITDA
180.22M
Income
87.23M
Revenue Q/Q
22.84%
Revenue Y/Y
180.06%
Profit margin
8.5%
Oper. margin
-3.23%
Gross margin
108.6%
EBIT margin
-3.23%
EBITDA margin
80.95%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

DRI Healthcare Trust stock price history

DRI Healthcare Trust stock forecast

DRI Healthcare Trust financial statements

DRI Healthcare Trust (TSX:DHT-U.TO): Profit margin
Jun 2023 115.82M 75.03M 64.78%
Sep 2023 24.90M -3.78M -15.18%
Dec 2023 56.86M 22.17M 39%
Mar 2024 25.05M -6.19M -24.73%
3.08%
Yield TTM
DRI Healthcare Trust (TSX:DHT-U.TO): Payout ratio
Payout ratio 271.84%
DRI Healthcare Trust (TSX:DHT-U.TO): Dividend Yield
2020
2021 2.05%
2022 9.22%
2023 7.73%
DRI Healthcare Trust (TSX:DHT-U.TO): Debt to assets
Jun 2023 720343000 299.14M 41.53%
Sep 2023 811522000 251.62M 31.01%
Dec 2023 834957000 273.46M 32.75%
Mar 2024 903449000 351.74M 38.93%
DRI Healthcare Trust (TSX:DHT-U.TO): Cash Flow
Jun 2023 9.50M 174.79M -73.42M
Sep 2023 3.63M -197.94M 101.19M
Dec 2023 44.13M -1.25M -8.24M
Mar 2024 56.07M -116.44M 64.10M

DRI Healthcare Trust other data

  • What's the price of DRI Healthcare Trust stock today?

    One share of DRI Healthcare Trust stock can currently be purchased for approximately $5.65.

  • When is DRI Healthcare Trust's next earnings date?

    Unfortunately, DRI Healthcare Trust's (DHT-U.TO) next earnings date is currently unknown.

  • Does DRI Healthcare Trust pay dividends?

    Yes, DRI Healthcare Trust pays dividends and its trailing 12-month yield is 3.09% with 272% payout ratio.It means that the company is paying a dividend greater than earnings. The last DRI Healthcare Trust stock dividend of undefined was paid on 6 Sep 2025.

  • How much money does DRI Healthcare Trust make?

    DRI Healthcare Trust has a market capitalization of 461.45M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 47.04% to 117.44M US dollars.

  • What is DRI Healthcare Trust's stock symbol?

    DRI Healthcare Trust is traded on the TSX under the ticker symbol "DHT-U.TO".

  • What is DRI Healthcare Trust's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of DRI Healthcare Trust?

    Shares of DRI Healthcare Trust can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When DRI Healthcare Trust went public?

    DRI Healthcare Trust is publicly traded company for more then 4 years since IPO on 11 Feb 2021.

  • What is DRI Healthcare Trust's official website?

    The official website for DRI Healthcare Trust is dricapital.com.

  • Where are DRI Healthcare Trust's headquarters?

    DRI Healthcare Trust is headquartered at 1 First Canadian Place, Toronto, ON.

  • How can i contact DRI Healthcare Trust?

    DRI Healthcare Trust's mailing address is 1 First Canadian Place, Toronto, ON and company can be reached via phone at +41 68631865.

DRI Healthcare Trust company profile:

DRI Healthcare Trust

dricapital.com
Exchange:

TSX

Full time employees:

0

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

1 First Canadian Place
Toronto, ON M5X 1B1

:
ISIN: CA23344H1091
: